Article ; Online: Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.
Genetics in medicine : official journal of the American College of Medical Genetics
2011 Volume 13, Issue 3, Page(s) 230–254
Abstract: Purpose: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort.: Methods: Cumulative percentiles of amino acids and acylcarnitines in dried blood spots of ... ...
| Abstract | Purpose: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort. Methods: Cumulative percentiles of amino acids and acylcarnitines in dried blood spots of approximately 25–30 million normal newborns and 10,742 deidentified true positive cases are compared to assign clinical significance, which is achieved when the median of a disorder range is, and usually markedly outside, either the 99th or the 1st percentile of the normal population. The cutoff target ranges of analytes and ratios are then defined as the interval between selected percentiles of the two populations. When overlaps occur, adjustments are made to maximize sensitivity and specificity taking all available factors into consideration. Results: As of December 1, 2010, 130 sites in 45 countries have uploaded a total of 25,114 percentile data points, 565,232 analyte results of true positive cases with 64 conditions, and 5,341 cutoff values. The average rate of submission of true positive cases between December 1, 2008, and December 1, 2010, was 5.1 cases/day. This cumulative evidence generated 91 high and 23 low cutoff target ranges. The overall proportion of cutoff values within the respective target range was 42% (2,269/5,341). Conclusion: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Amino Acids/blood ; Carnitine/analogs & derivatives ; Carnitine/blood ; Humans ; Infant, Newborn ; International Cooperation ; Metabolic Diseases/diagnosis ; Neonatal Screening ; Reference Values ; Sensitivity and Specificity ; Software ; Tandem Mass Spectrometry | |||||
| Chemical Substances | Amino Acids ; acylcarnitine ; Carnitine (S7UI8SM58A) | |||||
| Language | English | |||||
| Publishing date | 2011-02-08 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Validation Study | |||||
| ZDB-ID | 1455352-1 | |||||
| ISSN | 1530-0366 ; 1098-3600 | |||||
| ISSN (online) | 1530-0366 | |||||
| ISSN | 1098-3600 | |||||
| DOI | 10.1097/GIM.0b013e31820d5e67 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5059: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.